The novel therapy of the medication represents a major development in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide741223.blogars.com/40498278/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment